A Message from TargetCancer Foundation President Kristen Palma: When TCF was founded in 2009, we started around the kitchen table. It was Paul, myself and my...
Welcome, Hetal!
read more
News
Highlighting Our History
In honor of our 15th anniversary, TCF created videos that were featured at the TargetCancer Foundation Gala in April. These three videos each focus on a...
Reflections on 15 Years of TargetCancer Foundation
This milestone of TargetCancer Foundation’s 15 year anniversary has stopped me in my tracks. It is a long time to be doing this work and a long time to grieve...
2023: An Impactful Year In Review
RESEARCH → TCF-001 TRACK Our fully remote, decentralized precision medicine clinical trial has enrolled 157 patients with 40 rare cancers from 41 states,...
Thank you to our Community Fundraisers!
February is Cholangiocarcinoma Awareness Month. We are proud to highlight the many efforts from TCF community members who are working to bring attention to...
TCF Executive Director Jim Palma to Receive the 2022 Ruesch Center Luminary Award in GI Cancers
We are incredibly proud to announce that our Executive Director Jim Palma has been named a Ruesch Center 2022 Luminary Awards in GI Cancer recipient! The...
A Reflection of Purpose After 13 years: Remembering Our Founder
Written by Kristen Palma, TargetCancer Foundation President Each year, as I sit down to write this note, I wonder what more I can say. It has been 13...
Introducing Giselle Mota, our Newest Volunteer!
We are pleased to introduce you to TargetCancer Foundation's newest volunteer, Giselle Mota. Originally from Los Angeles, CA, Giselle currently resides in...
Promising New Cholangiocarcinoma Treatment Findings
An exciting paper was recently published in Cancer Discovery highlighting the promise of the recently FDA approved FGFR inhibitor drugs for an even broader...
Breaking New Ground: FDA Approves Pemazyre, the First Targeted Therapy for Cholangiocarcinoma
In the midst of such a challenging time, I wanted to take a moment to share some very positive and exciting news with you. Late last week, the FDA granted...
In Julienne’s Footsteps: Climbing Mt. Kilimanjaro to Honor a Life
By guest writer Karen Dempsey The bonds that Julienne Morriss Callaway forged and the values she embraced in life have been instrumental in sustaining her...
An Insider’s Perspective
Dr. Monika Laszkowska, a gastroenterology fellow, next to the poster she presented at the 2019 TargetCancer Foundation Think Tank on Advancing...
2019 Cholangiocarcinoma Research Grant Announcement
TargetCancer Foundation is proud to announce a new two-year, $240,000 grant to the Bardeesy Lab at the Massachusetts General Hospital Cancer Center brings our...
Building the Tools of Cholangiocarcinoma Research – A Researcher’s Reflection.
In December 2019, TargetCancer Foundation announced $240,000 in new cholangiocarcinoma grant funding. The following post was written by Grant Recipient Nabeel...
10 Years Ago Today
Today TargetCancer Foundation remembers our founder, Paul Poth, whose life was taken by cholangiocarcinoma at age 39 on this day ten years ago- August 22,...